As the kidney recipient pool ages, it is increasingly common to find living kidney donors who are the adult offspring of recipients.
A recent study reported that kidney transplant recipients of offspring living donors had higher graft loss and mortality. This seemed counterintuitive, given the excellent HLA matching and younger age of offspring donors; we were concerned about residual confounding and other study design issues. We used Scientific Registry of Transplant Recipients data 2001-2016 to evaluate death-censored graft failure (DCGF) and mortality for recipients of offspring versus nonoffspring living donor kidneys, using Cox regression models with interaction terms. Recipients of offspring kidneys had lower DCGF than recipients of nonoffspring kidneys (15-year cumulative incidence 21.2% vs 26.1%, P < .001). This association remained after adjustment for recipient and transplant factors (adjusted hazard ratio [aHR] = 0.73 0.77 0.82 , P < .001), and was attenuated among African American donors (aHR 0.77 0.85 0.95 ; interaction: P = .01) and female recipients (aHR 0.77 0.84 0.91 , P < .001). Although offspring kidney recipients had higher mortality (15-year mortality 56.4% vs 37.2%, P < .001), this largely disappeared with adjustment for recipient age alone (aHR = 1.02 1.06 1.10 , P = .002) and was nonsignificant after further adjustment for other recipient characteristics (aHR = 0.93 0.97 1.01 , P = .1). Kidneys from offspring donors provided lower graft failure and comparable mortality. An otherwise eligible donor should not be dismissed because they are the offspring of the recipient, and we encourage continued individualized counseling for potential donors.
K E Y W O R D S
donors and donation: living, ethnicity/race, graft survival, health services and outcomes research, kidney transplantation/nephrology, kidney transplantation: living donor In our philosophical framework, the age and human leukocyte antigen (HLA) matching of an offspring donor should be considered mediators of the offspring relationship when examining their recipient's outcomes. That is, the excellent HLA matching of parentoffspring pairs should confer an advantage in graft survival, 3 and offspring donors should generally be younger, and thus confer lower risk of graft loss. 4 Cohen et al initially sought to examine whether donor-specific alloimmunization during female recipients' pregnancies with their offspring donors conferred worse outcomes, and thus adjusted for donor age and number of HLA matches in order to isolate specifically the impact of offspring donor relationship.
However, by making conclusions regarding the effect of donor age, HLA matches, and offspring relationship separately, they have analyzed factors independently that, instead, are related as mediators of the offspring relationship.
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To understand better the impact of offspring donors, we used 2 | ME THODS
| Data source
This study used data from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all do-
nors, waitlisted candidates, and transplant recipients in the United
States, submitted by the members of the Organ Procurement and
Transplantation Network (OPTN), and has been described elsewhere. 10 The Health Resources and Services Administration, US Department of Health and Human Services provides oversight to the activities of the OPTN and SRTR contractors.
| Study population
We studied 91 665 adult living donor kidney-only recipients between 2001 and 2016. We excluded situations where donors were labeled as offspring but the age difference between recipient and donor was <10 years (N = 36). The youngest age of offspring kidney recipients was 36 years; accordingly, we excluded nonoffspring kidney recipients younger than 36 years (N = 17 508). We further excluded recipients with missing body mass index (BMI) or BMI outside the range of 15-45 (N = 1301).
| Posttransplant outcomes
We compared cumulative incidence of death-censored graft failure (DCGF) and mortality of offspring kidney recipients versus nonoffspring kidney recipients. We used Cox proportional hazards regression to describe the adjusted hazard ratio (aHR) of each outcome, adjusting for recipient covariates, and donor covariates described below. We graphed cumulative incidence of DCGF and mortality for offspring kidney recipients and nonoffspring kidney recipients using Kaplan-Meier methods. 
| Recipient factors

| Donor factors
We considered donor characteristics of age and number of HLA matches as mediators of the association between offspring status and posttransplant outcomes; that is, recipients of offspring kidneys would, by the nature of their donor being their child, have a younger donor than recipients of nonoffspring kidneys whose donor is not their child. We performed formal mediation analysis using the methods of Baron and Kenny 11 as well as Sobel tests to determine whether this mediation was statistically significant. 12 Thus, we report characteristics of offspring and nonoffspring donors but did not adjust for these characteristics in our regression models. In compari- 
| Effect modification by donor race/ ethnicity and recipient gender
We repeated our analysis incorporating interaction terms between offspring donor relationship and African American race as well as offspring donor relationship and Hispanic ethnicity in order to explore whether the association differs by race/ethnicity. We also incorporated interaction terms between offspring donor relationship and recipient gender in order to explore whether graft loss varied between mothers vs fathers of offspring donors. 
| Statistical analysis
We used the Wilcoxon rank sum test for continuous variables, χ 2 test for categorical variables, and log rank test for cumulative incidence.
An α of 0.05 was considered significant. Confidence intervals are reported as per the method of Louis and Zeger. 13 All analyses were performed using Stata 14.0/MP for Linux (College Station, TX). 
| RE SULTS
| Study population
| Confounding in previous study
| Mortality
Recipients of offspring kidneys had higher mortality than recipients of nonoffspring kidneys (crude 15-year mortality: 56.4% vs 37.2%, P < .001) (Figure 2 
| Death-censored graft failure
Recipients of offspring kidneys had lower DCGF than recipients of nonoffspring kidneys (crude 15-year DCGF: 21.2% vs 26.1%, P < .001) (Figure 3 ). After adjustment for recipient factors, offspring kidneys were associated with 23% lower risk of DCGF (total effect of offspring relationship: aHR 0.73 0.77 0.82 , P < .001) ( Table 2 ).
Examining how donor age and HLA mismatches are mediators in the association between offspring relationship and DCGF, the indirect effect of offspring relationship through donor age was a 17% higher risk of DCGF (per 10 years donor age, aHR 1.14 1.17 1.20 , P < .001). The indirect effect of offspring relationship through HLA mismatches was an 11% higher risk of DCGF (per HLA mismatch, aHR 1.09 1.11 1.13 , P < .001). The direct effect of offspring relationship after adjusting for donor age and HLA mismatches was a 13%
higher risk of DCGF (aHR 1.05 1.13 1.22 , P = .002). Sobel test estimates confirmed statistically significant mediation of offspring relationship through donor age (P < .001) and HLA mismatches (P < .001). That is, the lower risk of DCGF of offspring kidneys is mediated by the younger age and better HLA matching of offspring donors.
| Effect modification by donor race/ ethnicity and recipient gender
The association of having an offspring donor with a lower risk of DCGF was attenuated for African American donors (P value of interaction term: 0.01) ( 
| D ISCUSS I ON
Using national registry data, we studied the association between offspring donor kidney transplantation and graft loss and mortality among living donor recipients between 2001 and 2016. Offspring kidney recipients were older than nonoffspring kidney recipients, but their donors were younger than the donors of nonoffspring kidneys. While more than 97% of offspring transplants had 3 or fewer HLA mismatches, only 42% of nonoffspring transplants had 3 or fewer HLA mismatches. After adjustment for recipient characteristics, recipients of offspring kidneys had 23% lower risk of DCGF compared to recipients of nonoffspring kidneys (aHR 0.73 0.77 0.82 , P < .001), and a similar risk of mortality (aHR 0.93 0.97 1.01 , P = .1).
The lower risk of DCGF was attenuated among African American donors and among mothers who received offspring donor kidneys.
However, even among recipients of kidneys from African American donors, graft failure risk of offspring kidneys was still 15% lower than nonoffspring kidneys, and among mothers who received offspring donor kidneys, graft failure risk was 16% lower than nonoffspring kidneys.
Our findings of a comparable mortality risk between offspring kidneys and nonoffspring kidneys are in contrast to recent suggestions that offspring donor kidneys had higher mortality risk. 2 We believe this is due to residual confounding by categorization of a continuous variable. 14 Cohen et al adjusted their analysis for recipient age, but used a categorical variable for age with all recipients over 55 years old as 1 category. Within the category of recipients >55 years old, offspring kidney recipients were still much older than nonoffspring kidney recipients. We found that the higher mortality risk largely disappeared after adjusting for continuous recipient age alone (aHR 1.02 1.06 1.10 , P = .002), and became nonsignificant after further adjustment for other characteristics.
Our findings of a lower risk of graft failure from offspring donor kidneys also counter the recent report that offspring kidneys had higher risk of graft failure than nonoffspring kidneys. In conclusion, willing adult offspring remain excellent potential donors for patients in need of kidney transplantation. Although the magnitude of decreased risk of graft loss varies by donor race/ ethnicity and recipient gender, the younger donor age and HLA matching of offspring donors confer better graft survival than nonoffspring donors. We recommend that donor evaluation continue to include both personalized counseling regarding the potential donor's risk of future kidney disease as well as respect for autonomy in the informed consent process. 
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